First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors
Article in Journal for ImmunoTherapy of Cancer (October 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (October 2022)
Article in Nature Communications (June 2022)
Article in Scientific Reports (July 2019)